SLGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Sol-Gel Technologies Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 19, 2026
$64.98+0.73 (+1.14%)
Close on Oct 19, 2026
- Market cap
- $212.52M
- P/E (TTM)
- –
- Dividend yield
- –
Sol-Gel Technologies Ltd. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q2 25 | Q2 24 | Q2 23 | Q2 22 | Q2 21 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Sale of IP and license revenue [Member] | $460.00K | $16.72M | $4.80M | $380.00K | $3.52M | $0 | 77.8% | -97.2% |
| Support services [Member] | $131.00K | $14.00K | $21.00K | – | – | – | 22.2% | +835.7% |
| Royalties revenue [Member] | $0 | $530.00K | $612.00K | $214.00K | – | – | 0.0% | -100.0% |
| COLLABORATION REVENUES | – | – | – | – | $0 | $928.00K | – | – |
| Support services [Member] | – | – | $21.00K | $0 | – | – | – | – |
| Sale of IP [Member] | – | $16.00M | $4.80M | – | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of Sol-Gel Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.